Gene clusters found in bacterial species classified as Streptomyces encode the majority of known antibiotics as well as many pharmaceutically active compounds. A site-specific recombination system similar to those that mediate plasmid conjugation was engineered to catalyze tandem amplification of one of these gene clusters in a heterologous Streptomyces species. Three genetic elements were known to be required for DNA amplification in S. kanamyceticus: the oriT-like recombination sites RsA and RsB, and ZouA, a site-specific relaxase similar to TraA proteins that catalyze plasmid transfer. We inserted RsA and RsB sequences into the S. coelicolor genome flanking a cluster of 22 genes (act) responsible for biosynthesis of the polyketide antibiotic actinorhodin. Recombination between RsA and RsB generated zouAdependent DNA amplification resulting in 4-12 tandem copies of the act gene cluster averaging nine repeats per genome. This resulted in a 20-fold increase in actinorhodin production compared with the parental strain. To determine whether the recombination event required taxon-specific genetic effectors or generalized bacterial recombination (recA), it was also analyzed in the heterologous host Escherichia coli. zouA was expressed under the control of an inducible promoter in wild-type and recA mutant strains. A plasmid was constructed with recombination sites RsA and RsB bordering a drug resistance marker. Induction of zouA expression generated hybrid RsB/RsA sites, evidence of site-specific recombination that occurred independently of recA. ZouA-mediated DNA amplification promises to be a valuable tool for increasing the activities of commercially important biosynthetic, degradative, and photosynthetic pathways in a wide variety of organisms.
gene duplication | mutagenesis T andem amplifications of genomic DNA occur in all domains of life including humans, plants, insects, yeast, and bacteria (1) (2) (3) (4) and are proposed to be "the principle source of new genes" (for references, see ref. 4) . In bacteria, DNA amplification plays a role in antibiotic resistance, chromosome instability, gene evolution, and increasing the level of gene expression (4) (5) (6) (7) (8) . Regulated amplification of genes or gene clusters could also be a means of activating gene expression that is inherited over subsequent generations (6) . As a biotechnological tool, the inducible amplification of specific regions of microbial genomes (amplifiable or amplified units of DNA; AUDs) could have important applications in strain improvement for a wide variety of complex multigene processes, such as the biosynthesis of pharmaceutically active metabolites and vitamins, bioconversions, photosynthesis, and the degradation of toxic compounds.
About half of all agriculturally and pharmaceutically important compounds, including the majority of antibiotics, are produced by Actinomycetes (most belonging to the Streptomyces genus) or fungi (9) . Almost all of these "secondary metabolites" are encoded by gene clusters (9) (10) (11) (12) . When these clusters of genes are expressed, intermediates of primary metabolism are redirected to alternative pathways, generating antibiotics and other compounds with unusual structures and useful pharmaceutical and agricultural activities. However, when such gene clusters are transferred to heterologous hosts, levels of production are often low (13) (14) (15) (16) , presumably reflecting important metabolic and/or regulatory interactions with their native hosts.
An important factor in the commercial production of antibiotics and other pharmaceutically active secondary metabolites is the cost of strain improvement for increased yields. Yield improvement typically involves years of repeated cycles of mutagenesis and screening, potentially generating mutants in both primary and secondary metabolism (17) . For example, these mutations may change primary metabolic flux to increase precursor availability (17) . Rate-limiting steps for antibiotic production are also often associated with the secondary metabolic pathway itself, and some overproducing strains of Penicillium chrysogenum, S. lincolnensis, and S. kanamyceticus obtained in traditional screening programs contain amplifications of their antibiotic biosynthetic gene clusters (18) (19) (20) (21) . Detailed analysis of penicillin production strains derived by repeated rounds of mutagenesis and screening at different pharmaceutical companies revealed that independent lineages contained a progressively increasing number of tandem amplifications of the 57-kb biosynthetic gene cluster (18, 19) . Our studies of a kanamycin-overproducing strain of S. kanamyceticus revealed that its genome contained 36 tandem copies of a 145-kb DNA sequence that included the kanamycin biosynthetic gene cluster (21) . A major group of secondary metabolites, the polyketides, have commercial importance or potential applications as antibacterials, antifungals, antiparasitics, animal growth promotants, or immunosuppressants (22) . Polyketide biosynthetic pathways are encoded by clusters of genes ranging in size from around 20 kb to more than 100 kb (23) . These observations suggest that controlled, stable amplification of entire antibiotic biosynthetic gene clusters would be a valuable and generally applicable tool for engineering highyielding production strains.
In Escherichia coli and Salmonella, gene duplication-amplification (GDA) is typically initiated via recA-independent recombination between microhomologous sequences (imperfect matches of less than 20 bp) to generate a tandem duplication (3, 6, 7, (24) (25) (26) (27) . Subsequent amplification requires recA-dependent recombination. Such amplifications are generally restricted in size and unstable without continuous selection or recA inactivation (7, 25, 28) . Although gene amplifications in Streptomyces species have been described (29) (30) (31) , the specific enzymes and sequences required to generate and maintain them are not known. In S. lividans, such amplifications are relatively short, relying on two 4.7-kb repeats that amplify a 1-kb section of intervening sequence (29, 31) .
A previous report described DNA amplification in S. kanamyceticus that required zouA, two recombination sites (32) , and perhaps other host-specific factors, whereas possible mechanisms of amplification were discussed in ref. 21 . zouA encodes a TraAlike protein with two domains that are homologous to those that mediate plasmid conjugation in a wide variety of bacteria. One domain encodes a putative relaxase (similar to TrwC), and the other encodes a helicase/single-strand exonuclease (similar to Tra_Ti). They are usually part of a protein complex that interacts with specific sequences in plasmid origins of transfer (oriT)-mediating replication and recombination events that initiate and terminate conjugal transfer of single-stranded DNA. In addition to TraA homologs, many plasmids rely on additional plasmid-or host-encoded proteins to catalyze a series of reactions needed for plasmid transfer, including DNA bending, nicking, helical unwinding, and recombination (33, 34) . Transfer of Streptomyces plasmids is unlike all other bacterial conjugation systems in that it requires only one plasmid-encoded protein (translocase; TraB) that recognizes plasmid sequence motifs and catalyzes transfer of unnicked double-stranded DNA (35) . Although TraA homologs are encoded by some Streptomyces plasmids, their role in plasmid transfer has been questioned (36) . In S. kanamyceticus, sitespecific recombination takes place between two sequences (RsA and RsB) flanking the 145-kb AUD. RsA and RsB, which are likely to have functions analogous to oriT, are nearly identical in their first 16 bp (two mismatches). Tra genes (similar to zouA) catalyze RecA-independent site-specific recombination (34) that may generate gene amplifications in plasmids (37) . Here we describe the use of genetic cassettes containing S. kanamyceticus zouA and recombination sites RsA and RsB to amplify a polyketide (actinorhodin) biosynthetic gene cluster in its native S. coelicolor A3(2) host to generate an overproducing strain. We also demonstrate that the zouA, RsA/RsB-dependent recombination system functions in E. coli.
Results
Use of zouA and Flanking RsA and RsB Sites to Amplify an Antibiotic Biosynthetic Gene Cluster in S. coelicolor. To introduce zouA and RsA and RsB at sites flanking the actinorhodin biosynthetic gene cluster (act) of S. coelicolor, the three genetic elements were first subcloned as two cassettes (I and II) into an E. coli vector able to transfer to S. coelicolor by conjugation. These two plasmids contained, in addition, sequences homologous to those flanking the act gene cluster ( Fig. 1 ; strain and plasmid constructions are described in SI Materials and Methods). Because the plasmids are unable to replicate in Streptomycetes, selection for the antibiotic resistance genes carried by each vector resulted in their insertion into the S. coelicolor genome by homologous recombination with the sequences flanking the act gene cluster. MT617 contained all three elements, with RsA and RsB flanking the act cluster and with an apramycin resistance gene located in the potential AUD. Two control strains were constructed that did not have a functional zouA gene; one contained both recombination sites (MT717) and the other contained only RsB (MT17).
Generating Actinorhodin-Overproducing Cultures by Selective Enrichment. To enrich for genetic variants that had amplified the act gene cluster, M17, MT617, and MT717 were passaged five times (generations one-five; G1-G5) by 1/25 dilution in medium containing progressively increasing concentrations of apramycin (50-800 μg/mL) ( Fig. 2A) . Samples of these cultures were inoculated onto R5
− agar medium (apramycin 50-500 μg/mL) to visualize production of the blue-pigmented and diffusible actinorhodin and to produce spore stocks ( Fig. 2A) . Whereas MT617 G5 made large amounts of actinorhodin, little was produced by MT17 G5 and MT717 G5 (Fig. 2B ). Spores from G1 and G5 were then used to inoculate liquid cultures lacking apramycin. MT617 G5 produced progressively more intense blue pigment, reaching 450 μg/mL actinorhodin after 3 d in culture (Fig. 2C ). Much smaller amounts of actinorhodin were produced by cultures of the parental strain and derivatives (MT17 and MT717) that lacked a functional zouA gene (all produced less than 20 μg/mL) (Fig. 2C) . (A) Regions of the S. kanamyceticus genome containing the three genetic elements essential for amplification (zouA, RsA, and RsB) were cloned into two cassettes and targeted to flank the actinorhodin biosynthetic gene cluster in the S. coelicolor genome by homologous recombination (Materials and Methods). act, actinorhodin biosynthetic genes; kan, kanamycin biosynthetic genes. (B) A schematic representation of the vectors delivering cassettes I and II and the genomic area that is targeted. Double-crossover clones were identified for pAB606 and pAB607 by screening for viomycin resistance and loss of kanamycin resistance. Double-cross-over clones for pAB1004 were confirmed by Southern blot analyses. These plasmids were used to construct strains MT17 (pAB1004), MT617 (pAB1004 and pAB606), and MT717 (pAB1004 and pAB607). Cassette I was inserted either between positions 138,040 and 138,051 (MT617) or at position 63,080 (MT6h17) (S. coelicolor genome accession number AL6458821). In both MT617 and MT6h17, cassette II was inserted at nucleotide position 167,240.
PCR was performed to determine whether increased actinorhodin production in MT617 G5 correlated with tandem repeats of the act gene cluster within the presumed AUD. Genomic DNAs of MT617 and MT717 from generations 1, 3, and 5 were analyzed using primers designed to detect a potential recombination event generated at the junctions of head-to-tail tandem repeats (Fig. 3A) . If such tandem copies were generated by site-specific recombination between RsA and RsB, they would generate a 1.2-kb PCR product that included a hybrid RsB/RsA sequence (Fig. 3A) . A single PCR fragment of this size was indeed detected, and its intensity progressively increased as MT617 was passaged in medium containing increasing concentrations of apramycin (G1, G3, and G5) (Fig. 3B) . Nucleotide sequencing confirmed that it contained the recombinant RsB/RsA junction (Fig. 3A) , as observed previously in S. kanamyceticus (21) . Similar PCR analyses of genomic DNAs isolated from the MT717 or MT17 cultures (G1-G5) failed to amplify a 1.2-kb fragment. These results established that a specific amplification had occurred in MT617, that it was dependent on zouA, and that an ), which did not possess the amplification, also grew in the presence of increasing concentrations of apramycin (G1-G5). Because the parental strain (S. coelicolor MT1110) did not grow, growth of the control strains was presumably caused by spontaneous mutations that increased the level of expression of the apramycin resistance gene or the specific activity of the enzyme it encodes.
To analyze the correlation between the degree of amplification and the increase in actinorhodin production, total genomic DNAs were digested with NheI, an enzyme that did not cleave the AUD (Fig. 3A) . After separating fragments by pulsed-field gel electrophoresis (PFGE), they were hybridized to a probe adjacent to RsB (probe 1). The probe hybridized to the expected fragment (∼50 kb) containing a single copy of the AUD in genomic DNA from MT17 (G1, G5), MT617 (G1), and MT717 (G1, G5). In contrast, only amplified bands were observed in MT617 (G5) cultures that had been subjected to selection (Fig.  3C) . After five generations, there were at least seven bands ranging in size from 155 kb to >350 kb, demonstrating the presence of genomes that contained from 4 to more than 10 copies of the 35-kb AUD (Fig. 3C) . AUD copy numbers were also estimated by comparing the strength of hybridization signals corresponding to a fragment within the tandem repeats with a fragment present as a single copy at the genome-AUD border. This was done using a restriction enzyme (BsrG1) that had one cleavage site within the AUD sequence and a hybridization probe (probe 1) adjacent to RsB (Fig. 3A) . The relative intensities of the repeated and border fragments were quantified, indicating that the AUD in this mixed culture was amplified on average about 10 times (Fig. 3D) . Conceptually similar experiments using a different restriction enzyme to probe smaller fragments separated on standard agarose gels confirmed these results (Fig. S1) .
To determine whether larger segments of the S. coelicolor genome could be similarly amplified, a strain was constructed containing cassette II in the same position adjacent to the act cluster but with cassette I now inserted at a site about 60 kb away from the act cluster, potentially generating an AUD of 110 kb (Fig. 1A) . After growth in the presence of increasing concentrations of apramycin (MT6h17), the 1.2-kb PCR fragment indicative of an RsB/RsA junction in the mixed culture was detected (Fig. S2A) and confirmed by sequencing. This proved that the recombination event occurred between RsA and RsB sites separated by 110 kb. However, in contrast to the strain containing the 35-kb AUD (MT617), overproduction of actinorhodin was not observed (Fig. S2B) . Quantitative PCR showed that the RsB/RsA junctions were infrequent (about 1 per 228 genomes) for the 110-kb AUD, whereas the 35-kb AUD had about eight junctions per genome, indicating an ∼1,800-fold difference in amplification.
These genetic experiments demonstrated that zouA-dependent site-specific recombination between RsA and RsB was needed to generate tandem amplifications of the act gene cluster encoded within a 35-kb AUD and that this resulted in a 20-fold increase in actinorhodin production. When the act gene cluster was included in a larger AUD of 110 kb, recombination occurred at a much reduced frequency and the cultures did not overproduce actinorhodin.
Inducible, ZouA-Mediated Recombination of RsA and RsB in E. coli.
The discovery that only three components, RsA, RsB, and zouA, catalyzed recombination in a heterologous Streptomyces species led us to investigate whether this system could function in a distantly related bacterium such as E. coli, and whether it was dependent on the universal bacterial enzyme (RecA) catalyzing homologous recombination. Strains of E. coli that were recA [JM109(DE3)] or recA + [BL21(DE3)] were transformed with two plasmids: pRSFZ, with zouA expression under the control of an isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible promoter (Fig. S3) , and pAB707 (GenBank accession no. JN005928), which carried an engineered AUD containing an apramycin resistance gene (Fig. 4A) . The strains were grown in the presence of apramycin (50 μg/mL) with and without IPTG. The formation of an RsB/RsA junction was examined by PCR using primers designed to amplify a 584-bp DNA fragment (Fig. 4B) containing the hybrid junction. Formation of the RsB/RsA junction was induced by IPTG in both the recA − and recA + strains (Fig. 4B) , and the predicted RsB/RsA junction (Fig. 3A) was confirmed by sequencing. Thus, RsB/RsA recombination had occurred in a zouA-dependent, recA-independent manner. Due to the extremely high levels of resistance conferred by the apramycin resistance gene in pAB707 (>4 mg/mL), selective enrichment of plasmids containing tandem amplifications was not possible.
Discussion
Our studies demonstrated that three genetic elements identified in S. kanamyceticus (zouA, encoding a putative relaxase, and the specific recombination sites, RsA and RsB) were able to amplify specific segments of DNA in S. coelicolor. Four-to 12-fold (with an average of ninefold) amplification of a 35-kb region containing the act gene cluster resulted in a greater than 20-fold increase in actinorhodin production (MT617 G5). In contrast, when the same experiment was done using a strain (MT6h17) in which one of the recombination sites was located 60 kb away from the act cluster (Fig. 1A) , amplification occurred in less than 1% of the genomes. Although this difference could reflect the increased distance that separated the Rs sites in MT6h17 compared with MT617, it may also reflect the deleterious effects caused by amplification of sequences flanking the act gene cluster. In either case, it highlighted the importance of using sitespecific recombination to limit the amplification so as to include only the secondary metabolic gene cluster. This could be achieved by isolating large fragments of genomic DNA in heterologous hosts on plasmid vectors; however, the zouA-based system allowed relatively facile and stable amplification of a large region of a genome in its native host. The recombinant DNA methods used here should be broadly applicable to Streptomyces and other Actinomycetes species, and could be used to increase the level of production of commercially useful secondary metabolites or to discover new pharmaceutically active compounds by the specific amplification of cryptic gene clusters (38) . ; lanes 1-4) or BL21(DE3) (recA + ; lanes 5-8) using primers KM-16′ and SbfLN to detect the 584-bp RsB/ RsA fusion fragment. E. coli hosts contained no plasmid (lanes 1 and 5), pAB707 (lanes 2 and 6), pAB707 and pRSFZ uninduced (lanes 3 and 7) , or pAB707 and pRSFZ induced with IPTG (lanes 4 and 8) .
The complete genomic sequences of six actinobacteria (39) (40) (41) (42) (43) (44) have revealed many previously unknown secondary metabolic pathways. Each of these genomes encodes from 20 to 36 putative secondary metabolic gene clusters whose unknown products potentially include novel structures with pharmaceutical applications. zouA-based amplification of these cryptic gene clusters could be used to activate or enhance the production of their corresponding secondary metabolites, and contribute to muchneeded drug (particularly antibiotic) discovery.
The concept that GDA allows accelerated evolution of functions encoded by gene clusters is also important in the context of industrial strain development. As noted in the Introduction, overproducing strains generated by many cycles of empirical mutagenesis and screening often contain amplifications of antibiotic gene clusters. If the genome contains multiple copies of a metabolic gene cluster, it can sustain higher rates of mutagenesis, thus increasing the probability of beneficial mutations in genes encoding rate-limiting steps without loss of overall cluster function. Thus, not only are strains with ZouA-catalyzed amplifications of gene clusters likely to produce more product initially, they may also be ideal strains to use in traditional yield improvement programs of mutagenesis and screening.
Many species of Streptomyces generate stable genomic amplifications at high frequencies (around 1% of the colonies) in the absence of obvious selective pressure (29, (45) (46) (47) , in contrast to the instability of recA-dependent gene amplifications in E. coli (7, 25, 28) . In Streptomyces, as in other bacteria, the first step, namely duplication, is rate-limiting (47) . Our data strongly suggest that zouA, or perhaps other homologs traditionally associated with plasmid transfer, catalyze the initial duplication and/or the subsequent amplification. A TBLASTN analysis of the 30 sequenced Streptomyces genomes currently available on the National Center for Biotechnology Information/BLAST/microbe site (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) revealed significant matches only in Streptomyces sp. S4 [CADY01000194; a block of 1,092/1,439 (76%) identical amino acids] and Streptomyces sp. Mg1 [ABJF01000113; a block of 374/852 (44%) identical amino acids]. It is not known whether these proteins catalyze gene amplification. Whereas apramycin was needed to select for amplification of the act gene cluster in S. coelicolor, it was not needed to maintain the overproduction phenotype over a period of five passages in liquid culture; actinorhodin overproduction, and presumably the corresponding GDA, was stably maintained in the absence of apramycin selection (Fig. S4) .
Studies carried out in E. coli established that zouA could act as a site-specific recombinase in an evolutionary divergent taxon of bacteria. Remarkably, RsB/RsA junction fragments (Fig. 4B) were IPTG-inducible in both recA + and recA − hosts. By analogy to its ability to amplify genes in Streptomyces, ZouA may catalyze amplification of the sequence flanked by RsA and RsB in pAB707 (Fig. 4A) . Many site-specific recombination systems have evolved to eliminate deleterious duplications in plasmids or chromosomes (48, 49) . For example, Cre recombinase catalyzes site-specific recombination at the loxA site (34 bp) to resolve multimers of the P1 plasmid (49) . Whereas Cre and related recombinases favor resolution of duplications, they also catalyze the less favored reverse reaction that can generate gene duplication (50, 51) . Interestingly, although ZouA catalyzes a similar reaction between RsA and RsB, in contrast to Cre, we observed gene amplification in Streptomyces. This could simply reflect selective pressure for high copy number of the resistance gene; however, the fact that cluster amplifications were stably maintained in S. coelicolor in the absence of selection suggested that ZouA favors duplication. Although the ZouA-catalyzed recombination observed in E. coli may be indicative of gene amplification, further experiments will be required to isolate the resulting recombinant plasmids using selectable drug resistance markers.
Controlled amplification of gene clusters is likely to have important applications for increasing the productivity of commercially important processes in a wide range of bacteria. The zouA-mediated gene amplification in S. coelicolor reported here suggests that it could be used readily and immediately to increase levels of antibiotic biosynthesis in many Actinomycetes and possibly other microorganisms.
Materials and Methods
Bacterial Strains. E. coli DH5α, JM109(DE3) (Promega; P9801), BW25113 (52) harboring pIJ790 (53) , and ET12567 (54) harboring pUZ8002 (55) were used in this work. E. coli strains were cultivated in LB medium containing 1% tryptone, 0.5% yeast extract, and 0.5% NaCl supplemented with antibiotics as needed. Construction of plasmids for targeted recombination (PCR targeting) in S. coelicolor MT1110 (56) was performed as described by Gust et al. (53) . All other Streptomyces genetic manipulations were done according to Kieser et al. (55) .
Oligonucleotides. Oligonucleotide sequences are presented in Table S1 .
Plasmid and Strain Constructions. Construction of pAB601, pAB701, and pAB801 was described previously (57) . All other plasmids and strain constructions are described in SI Materials and Methods.
Culture Conditions for Actinorhodin Production. Seed cultures were grown at 30°C in 25 mL modified SOB medium (2% tryptone, 0.5% yeast extract, 0.05% NaCl, 2.5 mM KCl, MgCl2 omitted) with shaking at 140 rpm for 2 d. After homogenization, 5 mL was inoculated into 25 mL of R5MS (58) liquid medium. The culture was grown with shaking at 150 rpm at 30°C for 4 d. R5
− medium (59) (pH 7.2) was used for agar-grown cultures (30°C, 4 d).
Actinorhodin production was quantified by measuring the absorbance at 640 nm in 1 N KOH (55).
Pulsed-Field Gel Electrophoresis. S. coelicolor strains were grown in YEME (55) medium containing 0.5% glycine and 50 μg/mL apramycin for 48 h. Agarose plugs containing mycelium were prepared and restriction endonuclease digestions were performed (55) . A CHEF-DR III Pulsed-Field Electrophoresis System (Bio-Rad) was used to resolve DNA digests (60) in 1% agarose gels using 0.5% TBE (45 mM Tris-borate/1 mM EDTA) supplemented with 100 μM thiourea as the running buffer. Electrophoresis conditions varied depending on the size of the DNA fragments to be resolved (figure legends).
Southern Hybridization. DNA fragments from agarose gels were transferred to Amersham Hybond-N + sheets (GE Healthcare). Probe 1 (Fig. 3A) was an ∼3.4-kb SbfI-NdeI fragment of pAB1002 containing the apramycin resistance gene located adjacent to RsB. Probe 2 was an ∼3.5-kb NotI-XbaI fragment of pAB602 (Fig. 3A) . These probes were isolated using QIAquick Gel Extraction Kits (QIAGEN) and nonradioactively labeled using the ECL Amersham Kit (GE Healthcare). Hybridization, washing, and detection were performed according to the manufacturer's instructions.
IPTG-Induced Duplication in E. coli JM109(DE3)-and E. coli BL21(DE3)-Containing Plasmids pAB707/pRSFZ. E. coli JM109(DE3)/pAB707/pRSFZ and E. coli BL21 (DE3)/pAB707/pRSFZ were cultured overnight at 37°C, 200 rpm in 5 mL LB medium supplemented with kanamycin, ampicillin, and apramycin (50 μg/mL each). Two hundred fifty microliters of the culture was used to inoculate 25 mL of LB medium supplemented with glucose (0.5% wt/vol), kanamycin, ampicillin, and apramycin (50 μg/mL each), and grown at 37°C, 200 rpm to an OD 600 of 0.6. IPTG was added to the cultures to a final concentration of 1 mM, and the cultures were incubated overnight at 30°C, 150 rpm. DNA was isolated from the cultures using the illustra Kit (GE Healthcare) per the manufacturer's instructions. Control cultures of E. coli JM109(DE3) and E. coli BL21(DE3) were grown in parallel without antibiotics and IPTG. PCR analysis of the DNA was carried out at an annealing temperature of 55°C.
PCR Conditions. All PCR primers are listed in Table S1 . PCR was performed using TaKaRa LA Taq with GC Buffer (Takara Bio) according to the manufacturer's instructions, using an annealing temperature of 52°C unless otherwise specified. Reaction mixtures were supplemented with 0.5% dimethyl sulfoxide. All PCR was carried out with DNA isolated from cultures using the illustra Kit (GE Healthcare) per the manufacturer's instructions. For quantitative PCR, DNA samples were used undiluted or 1/4 diluted. In total, 2.5 μL DNA was used per 25 μL reaction. A mixture of PerfeCTa SYBR Green
